G. CENGİZ SEVAL Et Al. , "Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs," 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.134, Florida, United States Of America, 2019
CENGİZ SEVAL, G. Et Al. 2019. Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Florida, United States Of America).
CENGİZ SEVAL, G., KUZU, I., YÜKSEL, S., KAYGUSUZ, G., DALVA, K., ÖZCAN, M., ... BEKSAÇ, M.(2019). Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs . 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America
CENGİZ SEVAL, GÜLDANE Et Al. "Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs," 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2019
CENGİZ SEVAL, GÜLDANE C. Et Al. "Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America, 2019
CENGİZ SEVAL, G. Et Al. (2019) . "Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America.
@conferencepaper{conferencepaper, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs}, congress name={61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2019}}